ROL boosts revenues with strong demand, efficiency and acquisitions, but rising costs and weak liquidity weigh on margins.

HWM faces headwinds in commercial transportation, but its strength in aerospace is cushioning the impact.

Royal Caribbean's loyalty strength, digital adoption and exclusive destinations are powering growth in bookings and yields.

Best Buy Co Inc (NYSE:BBY) shares are down 6.3% at $70.71 this morning, reversing their morning gains even after the electronics retailer beat second-quarter estimates with earnings of $1.28 per share on revenue of $9.44 billion.

Ollie's Bargain Outlet Holdings, Inc. (NASDAQ:OLLI ) Q2 2026 Earnings Conference Call August 28, 2025 8:30 AM ET Company Participants Eric van der Valk - President, CEO & Director Robert F. Helm - Executive VP & CFO Conference Call Participants Bradley Bingham Thomas - KeyBanc Capital Markets Inc., Research Division Charles P.

LOS ANGELES, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

IBND offers exposure to investment grade corporate bonds from developed markets, with an unhedged profile benefiting from a weakening U.S. dollar. The fund's performance in 2025 has been driven by dollar weakness and lower European rates, not by its modest 2.6% yield. IBND is best suited for investors seeking diversification away from dollar-only holdings and looking to profit from further dollar depreciation.

LTRX posts Q4 revenue beat but sharp year-over-year decline, with Edge IoT momentum and new contracts setting up fiscal 2026 growth.

SHEL's Northern Lights joint venture project marks a milestone as CO2 injection begins, advancing Europe's carbon capture and storage efforts.

Football fans will still have games broadcast on Fox (FOXA) available to watch on YouTube TV, at least for now.

Bath & Body Works, Inc. (NYSE:BBWI ) Q2 2026 Earnings Conference Call August 28, 2025 8:00 AM ET Company Participants Daniel Heaf - CEO & Director Eva C. Boratto - Chief Financial Officer Luke Long - Corporate Participant Conference Call Participants Alexandra Ann Straton - Morgan Stanley, Research Division Dana Lauren Telsey - Telsey Advisory Group LLC Emily Ghosh - Goldman Sachs Group, Inc., Research Division Irwin Bernard Boruchow - Wells Fargo Securities, LLC, Research Division Jungwon Kim - TD Cowen, Research Division Katherine Read Delahunt - Morgan Stanley, Research Division Kelly Crago - Citigroup Inc., Research Division Lorraine Corrine …

I reiterate my buy rating on Blackstone, as the stock continues to outperform and the outlook remains highly positive. Falling interest rates and potential 401k access to private markets are major tailwinds, unlocking new capital pools for Blackstone. Blackstone's evergreen products like BREIT and BXPE are well positioned to capture increased retail and pension demand for private assets.

A group of protestors burst into the president of Microsoft's office earlier this week to demand the company cut ties with Israel.

GE Vernova's strong 2025 performance is driven by surging global electricity demand, especially from AI data centers, boosting its Electrification segment. Management recently raised its full-year 2025 guidance for revenue, EBITDA margin, and free cash flow, signaling that they expect the excellent financial performance to continue. A key catalyst is a turnaround in the Wind segment; progress here, especially on projects like Dogger Bank, could significantly lift investor sentiment.

Hims & Hers expands globally, while Amwell leans on federal contracts and software growth. Let's see which has the edge in earnings growth & strategic expansion.

ALNY's Amvuttra revenues surge with 89% sales growth in H1 and a key label expansion, but faces tough competition in the ATTR-CM market.

UBS has a list of alternatives for investors who think there is an AI bubble.

Sometimes, it's just not your year, despite still being at the top of your game. Costco Wholesale Corp. NASDAQ: COST reached a new all-time high of $1076 back in February, and appeared to be headed for another banner year following a fiscal Q2 2025 earnings beat.

Canadian Imperial Bank of Commerce (NYSE:CM ) Q3 2025 Earnings Conference Call August 28, 2025 7:30 AM ET Company Participants Frank Guse - Senior EVP & Chief Risk Officer Geoffrey M. Weiss - Senior Vice President, Investor Relations & Performance Measurement Hratch Panossian - Senior EVP and Group Head of Canadian Personal & Business Banking Robert Sedran - Senior EVP, CFO & Enterprise Strategy Shawn Beber - Senior EVP & Group Head of US Region Susan Rimmer - Corporate Participant Canadian Commercial Banking and Wealth Management - Corporate Participant Victor G.

Eli Lilly and Company's orforglipron shows strong efficacy and manufacturing advantages over Novo Nordisk's oral semaglutide, supporting future growth in the obesity and diabetes market. Orforglipron's convenience, scalability, and potential dual-indication label position it as a key driver for Eli Lilly's revenue diversification and premium valuation. Despite payer coverage and tolerability challenges, the massive eligible population and orforglipron's advantages should drive exponential sales growth.